Navigation Links
1 in 7 students has dabbled in 'smart' drugs
Date:11/14/2013

This news release is available in German.

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

Majority consumes soft enhancers

Around 94 percent of the students surveyed had already heard of neuroenhancement. 13.8 percent of these students had tried to improve their cognitive performance with prescription medication or legal or illegal drugs at least once during their degrees. The substance most used was alcohol (5.6%), followed by methylphenidate such as Ritalin (4.1%), sedatives and soporifics (2.7%), cannabis (2.5%), beta-blockers (1.2%), amphetamines (0.4%), and cocaine (0.2%).

The respondents primarily took these substances during the exam preparation period, only consuming stimulating substances rarely in the exam situation or for general stress during their degrees. While daily neuroenhancement was a rare occurrence (1.8%), the majority consumed "soft enhancers" such as caffeinated products, non-prescription vitamin products or herbal sedatives before their last big exam around a third even every day.

The number of Swiss students who take neuroenhancing drugs is comparable with recent studies conducted at European universities. "The purported frequency of neuroenhancement at Swiss universities needs to be put into perspective as we asked about psychoactive and calmative substances," says PD Michael Schaub, the study leader and head of the Swiss Research Institute for Public Health and Addiction.

Narrow majority obtained desired effect

As a rule, advanced students who also had a job alongside their degrees and reported higher stress levels consumed performance-enhancing substances more frequently. Certain differences were apparent depending on the degree course: In Switzerland, students of the subjects architecture (19.6%), journalism (18.2%), chemistry (17.6%), economics (17.1%), medicine (16.2%), or pharmaceutics (16.1%) had more experience of neuroenhancement than budding mathematicians (8.6%) or sports students (7%), for instance.

According to the survey, the intended effect was only achieved in a narrow majority of the students, which is why only around half would actually take these substances to boost their brain power again. "The development of neuroenhancement at Swiss universities should be monitored as students constitute a high-risk group that is exposed to increased stress and performance pressure during their degrees," concludes Schaub. "However, there is no need to intervene as yet."


'/>"/>

Contact: Dr. Michael Schaub
michael.schaub@isgf.uzh.ch
41-444-481-165
University of Zurich
Source:Eurekalert  

Related medicine news :

1. UMA Staff and Students Make 'Strides' to Fight Breast Cancer
2. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
3. EECPL Develops New Series of Management Games for MBA students
4. Smart Kids with Learning Disabilities Announces the 2014 Fred J. Epstein Youth Achievement Award Contest, Celebrating the Outstanding Accomplishments of Students with LD
5. Dissertation Mania will Provide Sample Research Papers to Master’s Students
6. The Therapist Development Center Now Awarding MSW Scholarships for Second Year MSW Students with the “Promising Futures in Clinical Social Work” Scholarship Program
7. After a concussion, students may need gradual transition back to academics
8. Starting from scratch: RIT program teaches first-year students how to learn
9. Colorado State University-Global Campus Launches New Initiative for Military Students: Operation EDU
10. Classroom Diaries becomes one-stop information provider and advisor for students
11. 20 Nursing Students Awarded 2013 APNA Board of Directors Student Scholarships by the American Psychiatric Nurses Association
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
1 in 7 students has dabbled in 'smart' drugs
(Date:2/17/2017)... Tampa, FL (PRWEB) , ... February 17, 2017 ... ... a premier sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 ... through Wednesday, Inspirata will showcase its anatomic and molecular pathology workflow solution, as ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists ... from February 21 - 23 in Beaver Creek, CO. It was announced today by ... second year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in the greater ... LifeNet 4 Families organization. , For more than 30 years, LifeNet 4 ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
(Date:2/16/2017)... ... 2017 , ... The Price Agency, a Jefferson County-based firm ... the Birmingham area, is announcing an ongoing charity event to help raise support ... son, Anius. , Anius is medically complex with diagnoses consisting and not limited ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... , Feb. 17, 2017   Parker ... protecting the rights of victims injured by medical ... regulators to call for better reporting. Congress required ... Safety concerns involving power morcellators and duodenoscopes ... to investigate how hospitals report injuries and deaths ...
(Date:2/17/2017)... February 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, ... The global ablation technologies market is expected to grow at a ... The market is expected to grow at a CAGR of 9.5% ... 2016, and $9.05bn in 2026. ... How this report will benefit you Read on ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
Breaking Medicine Technology: